Health-related quality of life in patients with different stages of liver disease induced by hepatitis C

References

• Seeff LB. The natural history of chronic hepatitis C virus infection. Clin Liver Dis 1997; 1: 587–602
   PubMedGoogle Scholar
• Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209–12
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29: 264–70
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr, Bayliss MS, Mannocchia M, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999; 30: 550–5
   PubMed Web of Science ®Google Scholar
• McHutchison JG, Ware JE, Jr, Bayliss MS, Pianko S, Albrecht JK, Cort S, et al. Hepatitis Interventional Therapy Group. The effects of interferon alpha-2b in combination with ribavirin on health-related quality of life and work productivity. J Hepatol 2001; 34: 140–7
   PubMed Web of Science ®Google Scholar
• Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 2737–44
   PubMed Web of Science ®Google Scholar
• Cordoba J, Flavià M, Jacas C, Vargas V, Jacas C, Alonso J, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39: 231–8
   PubMed Web of Science ®Google Scholar
• Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004; 39: 74–80
   PubMed Web of Science ®Google Scholar
• Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health-related quality of life: a systematic review and quantitative assessment. Hepatology 2005; 41: 790–800
   PubMed Web of Science ®Google Scholar
• Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology 2007; 45: 806–16
   PubMed Web of Science ®Google Scholar
• Ho SB, Nguyen H, Tetrick LL, Opitz GA, Basara ML, Dieperink E. Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population. Am J Gastroenterol 2001; 96: 157–64
   PubMed Web of Science ®Google Scholar
• Zickmund S, Ho EY, Masuda M, Ippolito L, LaBrecque DR. “They treated me like a leper”. Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003; 18: 835–44
   PubMed Web of Science ®Google Scholar
• Chong CA, Gulamhussein A, Heathcote EJ, Lilly L, Sherman M, Naglie G, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol 2003; 98: 630–8
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Callea F, Callea F, De Groote J, Gudat F, et al. Histological staging and grading of chronic hepatitis. J Hepatol 1995; 22: 696–9
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83
   PubMed Web of Science ®Google Scholar
• Sullivan, M, Karlsson, J, Ware, JE. SF-36 Health Survey: Swedish manual and interpretation guide, 2nd ed. Gothenburg: Sahlgrenska University Hospital; 2002.
   Google Scholar
• Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 1998; 316: 736–41
   PubMed Web of Science ®Google Scholar
• Burström K, Johannesson M, Rehnberg C. Deteriorating health status in Stockholm 1998–2002: results from repeated population surveys using the EQ-5D. Qual Life Res 2007; 16: 1547–53
   PubMed Web of Science ®Google Scholar
• Dolan P. Modeling valuation for EuroQoL health states. Med care 1997; 35: 1095–8
   PubMed Web of Science ®Google Scholar
• Wayne, WD. Biostatistics: A foundation for analysis in the health sciences, 6th ed. New York: John Wiley & Sons; 1991.
   Google Scholar
• Montgomery, DC. Design and analysis of experiment, 3rd ed., New York: John Wiley & Sons; 1991.
   Google Scholar
• Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Italian Study Group for Quality of Life in Cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170–8
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001; 96: 2199–205
   PubMed Web of Science ®Google Scholar
• van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, et al. Generic and disease-specific health-related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. Br Med C Gastroenterol 2003; 3: 33
   Google Scholar
• Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002; 35: 704–8
   PubMed Web of Science ®Google Scholar
• Hassanein T, Cooksley G, Sulkowski M, Smith C, Marinos G, Lai MY, et al. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. J Hepatol 2004; 40: 675–81
   PubMed Web of Science ®Google Scholar
• Björnsson E, Simren M, Olsson R, Chapman RW. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 351–7
   PubMed Web of Science ®Google Scholar
• Björnsson E, Simren M, Olsson R, Chapman RW. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2004; 39: 864–9
   PubMed Web of Science ®Google Scholar
• Hauser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004; 2: 157–63
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961; 6: 561–71
   Web of Science ®Google Scholar
• Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, et al. HALT-C Trial Group. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005; 43: 614–22
   PubMed Web of Science ®Google Scholar
• Ong SC, Mak B, Aung MO, Li SC, Lim SG. Health-related quality of life in chronic hepatitis B patients. Hepatology 2008; 47: 1108–17
   PubMed Web of Science ®Google Scholar
• Marcellin P, Lau GK, Zeuzem S, Heathcote EJ, Pockros PJ, Reddy KR. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int 2008; 28: 477–85
   PubMed Web of Science ®Google Scholar